US Patent Issued to Carrick Therapeutics on Nov. 18 for "4-[[(7-aminopyrazolo[1,5-apyrimidin-5-yl)amino methylpiperidin-3-ol compounds and their therapeutic use" (British, Irish Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,303, issued on Nov. 18, was assigned to Carrick Therapeutics Ltd. (Belfield, Ireland).

"4-[[(7-aminopyrazolo[1,5-apyrimidin-5-yl)amino methylpiperidin-3-ol compounds and their therapeutic use" was invented by Edward Ainscow (Dublin), Ashwani Bahl (Dublin), Mihiro Sunose (Nottingham, Great Britain), Damien Francis Philippe Crepin (Nottingham, Great Britain), Kamaldeep Kaur Chohan (Nottingham, Great Britain), Brett Stevenson (Nottingham, Great Britain) and Jason John Shiers (Nottingham, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention pertains generally to the field of therapeutic compounds. More specifically the pres...